Molnlycke Health Care
Stage
Acq - Fin - III | AliveAbout Molnlycke Health Care
Molnlycke Health Care is a manufacturer of single-use surgical and wound care products. The company's products help patients feel less pain and aid healthcare professionals to safer and more efficient surgery.
Missing: Molnlycke Health Care's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Molnlycke Health Care's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Molnlycke Health Care
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Molnlycke Health Care is included in 2 Expert Collections, including Diabetes.
Diabetes
1,904 items
Medical Devices
3,088 items
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Molnlycke Health Care Patents
Molnlycke Health Care has filed 19 patents.
The 3 most popular patent topics include:
- Biliary tract disorders
- Cancer fundraisers
- Charity fundraisers
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/25/2018 | 8/10/2021 | Rare diseases, Cancer fundraisers, Self care, Charity fundraisers, Biliary tract disorders | Grant |
Application Date | 5/25/2018 |
|---|---|
Grant Date | 8/10/2021 |
Title | |
Related Topics | Rare diseases, Cancer fundraisers, Self care, Charity fundraisers, Biliary tract disorders |
Status | Grant |
Latest Molnlycke Health Care News
Feb 23, 2023
News provided by Share this article Share this article Companies Mentioned Perrigo Company plc Scar treatment market is developing at a fast rate due to the growing awareness among people regarding aesthetics. The appearance of different types of scars poses a huge challenge to the day-to-day lifestyle of victims while affecting their aesthetic appeal. Hence, this factor is expected to develop an increased need for scar treatment. Acne scars are one of the most common concerns for women, which disrupt their aesthetic appeal, making them uncomfortable. Consequently, the demand for scar treatment products is expected to rise, owing to the growing concern for aesthetics. The aesthetic industry witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. Since the majority of procedures were not medical necessities, lockdowns in several countries led to the closure of beauty clinics, med spas, dermatology clinics, and retail stores. However, online consultancy helps patients overcome these problems. The increasing number of road accidents globally continues to lead to several face and body marks, which frequently need surgical treatment. As a result, patients who have undergone such procedures are usually given topical scar reduction products. Cosmetic surgeries using laser instruments are also gaining popularity to treat severe road accident scars. A victim's daily life is hampered by post-burn marks. Plastic surgeries or resurfacing laser therapies are being used to remove these marks. Scar removal products that are technologically advanced are widely available on the market, which reduces pain and makes scar treatment a simple process. For instance, UltraPulse by Lumenis uses CO2 laser to treat acne scars, which reduces the risk of pain during the treatment process. Scar Treatment Market Report Highlights Topical products dominated the market in 2022 due to the higher adoption of creams and gels for treating scars, such as acne, surgical marks, and burns Laser products are anticipated to witness the highest growth over the forecast period due to the continuous introduction of technically advanced laser instruments Atrophic scars held the largest share in 2022 as acne prevalence remains more common among women, who constitute the majority of the target population North America dominated the market in 2022 owing to the high penetration of laser-based products in scar treatment and skin rejuvenation Key Topics Covered: Chapter 2 Executive Summary 3.1 Market Lineage Outlook 4.5.2.2 Pulse-dyed Laser 4.5.2.3 Other Laser Products 4.5.3 Injectables 4.5.4 Others Chapter 5 Scar Treatment Market: Scar Type Estimates And Trend Analysis 5.1 Definition & Scope 5.3 Segment Dashboard 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 5.5.1 Atrophic Scars 5.5.1.2 Atrophic scars market, by product, 2018 to 2030 (USD Million) 5.5.2 Hypertrophic and Keloid Scars 5.5.2.1 Hypertrophic and keloid scars market, 2018 to 2030 (USD Million) 5.5.2.2 Hypertrophic and keloid scars market, by product, 2018 to 2030 (USD Million) 5.5.3 Contracture Scars 5.5.3.2 Contracture scars market, by product, 2018 to 2030 (USD Million) 5.5.4 Stretch Marks 5.5.4.2 Stretch marks market, by product, 2018 to 2030 (USD Million) Chapter 6 Scar Treatment Market: End-use Estimates And Trend Analysis 6.1 Definition & Scope 6.3 Segment Dashboard 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 6.5.1 Atrophic Scars
Molnlycke Health Care Frequently Asked Questions (FAQ)
Where is Molnlycke Health Care's headquarters?
Molnlycke Health Care's headquarters is located at Gamlestadsvagen 3C, Gothenburg.
What is Molnlycke Health Care's latest funding round?
Molnlycke Health Care's latest funding round is Acq - Fin - III.
Who are the investors of Molnlycke Health Care?
Investors of Molnlycke Health Care include Patricia Industries, Apex Venture Partners and Nordic Capital.
Who are Molnlycke Health Care's competitors?
Competitors of Molnlycke Health Care include NeoChord, OrthAlign, GENICON, Acelity, Nuvesse Skin Therapies and 13 more.
Compare Molnlycke Health Care to Competitors
Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.
Mpathy Medical has developed a range of less invasive surgical solutions to restore pelvic health to women. The company's responsive team aims to provide a relationship with the individuals who really matter, women and their surgeons.
CryoPen is a developer and manufacturer of state-of-the art medical devices and aesthetic treatment systems. CryoPen is committed to delivering the most effective, and profitable solutions available to healthcare providers, physicians of all specialties, and medical spas. The company's product portfolio aims to enable physicians to provide a higher quality of care and offer their patients a more diverse array of treatments while generating a substantial revenue stream for their practice. CryoPen's product set addresses a multitude of treatment applications such as laser hair removal, skin rejuvenation, cryosurgery, cellulite reduction, vascular lesions, pigmented lesions, acne, psoriasis, fine lines & wrinkles, scar and tattoo removal, photo facials, and skin tightening. With a dedication to the research and development of technologically advanced devices and equipment, every CryoPen product is designed to create a better patient experience, consistent clinical outcomes, and economic impact on the bottom line of their practice.
Novare Surgical Systems, Inc. develops atraumatic systems that aim to provide surgeons with unmatched confidence in and control of their surgical occlusion. With its engineered designs, the company aims to expand the surgical temporary occlusion markets of the U.S. and Europe, estimated to be worth up to $155 million each.
Zeno Corporation is a Houston-based medical technology company engaged in the development of products using its patented ClearPoint technologyˆ as well as other products related to skin care.
Cambridge Endoscopic Devices (CED) has developed a line of surgical instruments that aim to address the need for enhanced dexterity and manipulation in laparoscopic and endoscopic surgery. Per the company, these instruments overcome surgical barriers encountered with traditional endoscopic and laparoscopic instruments, allowing for the potential of new surgical procedures and better, more cost effective clinical outcomes.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.